Vertex Pharmaceuticals Incorporated - Company Profile and SWOT Analysis
Vertex Pharmaceuticals Incorporated %li%Company Profile and SWOT Analysis
Summary
Vertex Pharmaceuticals Incorporated %li%Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
Key Highlights
Vertex Pharmaceuticals Incorporated (Vertex or “the company”) involved in the discovery, development and commercialization of new medicines. The company operates R&D facilities in California, Washington D.C., Iowa, Switzerland, the UK, France, Germany, Australia, Canada, Ireland, Spain, Italy and the Netherlands. It offers products for cystic fibrosis (CF) treatment including Kalydeco (ivacaftor), Symdeko/Symkevi (tezacaftor/ivacaftor and ivacaftor), Trikafta/Kaftrio (elexacaftor/tezacaftor/ivacaftor and ivacaftor) and Orkambi (ivacaftor/lumacaftor). Vertex is involved in curing various disease including cancer, influenza, neurological diseases and disorders such as pain and cystic fibrosis. It primarily operates in the US, Canada and Europe. The company is headquartered in Boston, Massachusetts, the US.
Scope
Summary
Vertex Pharmaceuticals Incorporated %li%Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
Key Highlights
Vertex Pharmaceuticals Incorporated (Vertex or “the company”) involved in the discovery, development and commercialization of new medicines. The company operates R&D facilities in California, Washington D.C., Iowa, Switzerland, the UK, France, Germany, Australia, Canada, Ireland, Spain, Italy and the Netherlands. It offers products for cystic fibrosis (CF) treatment including Kalydeco (ivacaftor), Symdeko/Symkevi (tezacaftor/ivacaftor and ivacaftor), Trikafta/Kaftrio (elexacaftor/tezacaftor/ivacaftor and ivacaftor) and Orkambi (ivacaftor/lumacaftor). Vertex is involved in curing various disease including cancer, influenza, neurological diseases and disorders such as pain and cystic fibrosis. It primarily operates in the US, Canada and Europe. The company is headquartered in Boston, Massachusetts, the US.
Scope
- Detailed information on Vertex Pharmaceuticals Incorporated required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Vertex Pharmaceuticals Incorporated in the form of a SWOT analysis
- An in-depth view of the business model of Vertex Pharmaceuticals Incorporated including a breakdown and examination of key business segments
- Intelligence on Vertex Pharmaceuticals Incorporated's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Vertex Pharmaceuticals Incorporated, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
- Gain understanding of Vertex Pharmaceuticals Incorporated and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Vertex Pharmaceuticals Incorporated as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Vertex Pharmaceuticals Incorporated's business structure, strategy and prospects.
Table of Contents
Company Snapshot
Vertex Pharmaceuticals Incorporated: Company Overview
Vertex Pharmaceuticals Incorporated: Overview and Key Facts
Vertex Pharmaceuticals Incorporated: Overview
Vertex Pharmaceuticals Incorporated: Key Facts
Vertex Pharmaceuticals Incorporated: Key Employees
Vertex Pharmaceuticals Incorporated: Key Employee Biographies
Vertex Pharmaceuticals Incorporated: Major Products and Services
Vertex Pharmaceuticals Incorporated: Management Statement
Vertex Pharmaceuticals Incorporated: Locations and Subsidiaries
Vertex Pharmaceuticals Incorporated: Key Competitors
Vertex Pharmaceuticals Incorporated: Company Analysis
Vertex Pharmaceuticals Incorporated: Business Description
Vertex Pharmaceuticals Incorporated: SWOT Analysis
Vertex Pharmaceuticals Incorporated: SWOT Overview
Vertex Pharmaceuticals Incorporated: Strengths
Vertex Pharmaceuticals Incorporated: Weaknesses
Vertex Pharmaceuticals Incorporated: Opportunities
Vertex Pharmaceuticals Incorporated: Threats
Vertex Pharmaceuticals Incorporated: Corporate Financial Deals Activity
Vertex Pharmaceuticals Incorporated: Financial Deals Overview
Vertex Pharmaceuticals Incorporated: Targets and Partners
Vertex Pharmaceuticals Incorporated: Top Deals 2020 - 2024YTD*
Vertex Pharmaceuticals Incorporated: Advisors
Vertex Pharmaceuticals Incorporated: Top Legal Advisors
Vertex Pharmaceuticals Incorporated: Mergers and Acquisitions
Vertex Pharmaceuticals Incorporated: Corporate Venturing
Vertex Pharmaceuticals Incorporated: Partnership
Vertex Pharmaceuticals Incorporated: Recent Developments
Vertex Pharmaceuticals Incorporated: News and Events Summary
Vertex Pharmaceuticals Incorporated: Business Expansion
Vertex Pharmaceuticals Incorporated: Contracts
Vertex Pharmaceuticals Incorporated: Corporate Governance
Vertex Pharmaceuticals Incorporated: Corporate Social Responsibility
Vertex Pharmaceuticals Incorporated: Financial Performance
Vertex Pharmaceuticals Incorporated: Regulatory and Legal Events
Vertex Pharmaceuticals Incorporated: Research & Development
Vertex Pharmaceuticals Incorporated: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
Company Snapshot
Vertex Pharmaceuticals Incorporated: Company Overview
Vertex Pharmaceuticals Incorporated: Overview and Key Facts
Vertex Pharmaceuticals Incorporated: Overview
Vertex Pharmaceuticals Incorporated: Key Facts
Vertex Pharmaceuticals Incorporated: Key Employees
Vertex Pharmaceuticals Incorporated: Key Employee Biographies
Vertex Pharmaceuticals Incorporated: Major Products and Services
Vertex Pharmaceuticals Incorporated: Management Statement
Vertex Pharmaceuticals Incorporated: Locations and Subsidiaries
Vertex Pharmaceuticals Incorporated: Key Competitors
Vertex Pharmaceuticals Incorporated: Company Analysis
Vertex Pharmaceuticals Incorporated: Business Description
Vertex Pharmaceuticals Incorporated: SWOT Analysis
Vertex Pharmaceuticals Incorporated: SWOT Overview
Vertex Pharmaceuticals Incorporated: Strengths
Vertex Pharmaceuticals Incorporated: Weaknesses
Vertex Pharmaceuticals Incorporated: Opportunities
Vertex Pharmaceuticals Incorporated: Threats
Vertex Pharmaceuticals Incorporated: Corporate Financial Deals Activity
Vertex Pharmaceuticals Incorporated: Financial Deals Overview
Vertex Pharmaceuticals Incorporated: Targets and Partners
Vertex Pharmaceuticals Incorporated: Top Deals 2020 - 2024YTD*
Vertex Pharmaceuticals Incorporated: Advisors
Vertex Pharmaceuticals Incorporated: Top Legal Advisors
Vertex Pharmaceuticals Incorporated: Mergers and Acquisitions
Vertex Pharmaceuticals Incorporated: Corporate Venturing
Vertex Pharmaceuticals Incorporated: Partnership
Vertex Pharmaceuticals Incorporated: Recent Developments
Vertex Pharmaceuticals Incorporated: News and Events Summary
Vertex Pharmaceuticals Incorporated: Business Expansion
Vertex Pharmaceuticals Incorporated: Contracts
Vertex Pharmaceuticals Incorporated: Corporate Governance
Vertex Pharmaceuticals Incorporated: Corporate Social Responsibility
Vertex Pharmaceuticals Incorporated: Financial Performance
Vertex Pharmaceuticals Incorporated: Regulatory and Legal Events
Vertex Pharmaceuticals Incorporated: Research & Development
Vertex Pharmaceuticals Incorporated: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
LIST OF TABLES
Table 1: Vertex Pharmaceuticals Incorporated: Key Facts
Table 2: Vertex Pharmaceuticals Incorporated: Key Employees
Table 3: Vertex Pharmaceuticals Incorporated: Locations and Subsidiaries
Table 4: Vertex Pharmaceuticals Incorporated: Key Competitors
Table 5: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
Table 7: Vertex Pharmaceuticals Incorporated: M&A Average Deal Size - Value (US$m)
Table 8: Vertex Pharmaceuticals Incorporated: Targets and Partners
Table 9: Vertex Pharmaceuticals Incorporated: Top Deals 2020 - 2024YTD*
Table 10: Vertex Pharmaceuticals Incorporated: Legal Advisor Ranking by Value (US$m)
Table 11: Vertex Pharmaceuticals Incorporated: M&A Volume and Value Trend (2020 - YTD*2024)
Table 12: Vertex Pharmaceuticals Incorporated: M&A Activity by Geography (2020 - YTD*2024)
Table 13: Vertex Pharmaceuticals Incorporated: Corporate Venturing Volume and Value Trend (2020 - YTD*2024)
Table 14: Vertex Pharmaceuticals Incorporated: Corporate Venturing by Geography (2020 - YTD*2024)
Table 15: Vertex Pharmaceuticals Incorporated: Partnership Volume and Value Trend (2020 - YTD*2024)
Table 16: Vertex Pharmaceuticals Incorporated: Partnership Trend by Deal Type (2020 - YTD*2024)
Table 17: Vertex Pharmaceuticals Incorporated: News and Events Summary
Table 18: Vertex Pharmaceuticals Incorporated: Business Expansion
Table 19: Vertex Pharmaceuticals Incorporated: Contracts
Table 20: Vertex Pharmaceuticals Incorporated: Corporate Governance
Table 21: Vertex Pharmaceuticals Incorporated: Corporate Social Responsibility
Table 22: Vertex Pharmaceuticals Incorporated: Financial Performance
Table 23: Vertex Pharmaceuticals Incorporated: Regulatory and Legal Events
Table 24: Vertex Pharmaceuticals Incorporated: Research & Development
Table 25: Vertex Pharmaceuticals Incorporated: Strategy and Operations
Table 1: Vertex Pharmaceuticals Incorporated: Key Facts
Table 2: Vertex Pharmaceuticals Incorporated: Key Employees
Table 3: Vertex Pharmaceuticals Incorporated: Locations and Subsidiaries
Table 4: Vertex Pharmaceuticals Incorporated: Key Competitors
Table 5: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
Table 7: Vertex Pharmaceuticals Incorporated: M&A Average Deal Size - Value (US$m)
Table 8: Vertex Pharmaceuticals Incorporated: Targets and Partners
Table 9: Vertex Pharmaceuticals Incorporated: Top Deals 2020 - 2024YTD*
Table 10: Vertex Pharmaceuticals Incorporated: Legal Advisor Ranking by Value (US$m)
Table 11: Vertex Pharmaceuticals Incorporated: M&A Volume and Value Trend (2020 - YTD*2024)
Table 12: Vertex Pharmaceuticals Incorporated: M&A Activity by Geography (2020 - YTD*2024)
Table 13: Vertex Pharmaceuticals Incorporated: Corporate Venturing Volume and Value Trend (2020 - YTD*2024)
Table 14: Vertex Pharmaceuticals Incorporated: Corporate Venturing by Geography (2020 - YTD*2024)
Table 15: Vertex Pharmaceuticals Incorporated: Partnership Volume and Value Trend (2020 - YTD*2024)
Table 16: Vertex Pharmaceuticals Incorporated: Partnership Trend by Deal Type (2020 - YTD*2024)
Table 17: Vertex Pharmaceuticals Incorporated: News and Events Summary
Table 18: Vertex Pharmaceuticals Incorporated: Business Expansion
Table 19: Vertex Pharmaceuticals Incorporated: Contracts
Table 20: Vertex Pharmaceuticals Incorporated: Corporate Governance
Table 21: Vertex Pharmaceuticals Incorporated: Corporate Social Responsibility
Table 22: Vertex Pharmaceuticals Incorporated: Financial Performance
Table 23: Vertex Pharmaceuticals Incorporated: Regulatory and Legal Events
Table 24: Vertex Pharmaceuticals Incorporated: Research & Development
Table 25: Vertex Pharmaceuticals Incorporated: Strategy and Operations
LIST OF FIGURES
Figure 1: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
Figure 3: Vertex Pharmaceuticals Incorporated: M&A Average Deal Size - Value (US$m)
Figure 4: Vertex Pharmaceuticals Incorporated: M&A Volume and Value Trend (2020 - YTD*2024)
Figure 5: Vertex Pharmaceuticals Incorporated: M&A Activity by Geography (2020 - YTD*2024)
Figure 6: Vertex Pharmaceuticals Incorporated: Corporate Venturing Volume and Value Trend (2020 - YTD*2024)
Figure 7: Vertex Pharmaceuticals Incorporated: Corporate Venturing by Geography (2020 - YTD*2024)
Figure 8: Vertex Pharmaceuticals Incorporated: Partnership Volume and Value Trend (2020 - YTD*2024)
Figure 9: Vertex Pharmaceuticals Incorporated: Partnership Trend by Deal Type (2020 - YTD*2024)
Figure 1: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
Figure 3: Vertex Pharmaceuticals Incorporated: M&A Average Deal Size - Value (US$m)
Figure 4: Vertex Pharmaceuticals Incorporated: M&A Volume and Value Trend (2020 - YTD*2024)
Figure 5: Vertex Pharmaceuticals Incorporated: M&A Activity by Geography (2020 - YTD*2024)
Figure 6: Vertex Pharmaceuticals Incorporated: Corporate Venturing Volume and Value Trend (2020 - YTD*2024)
Figure 7: Vertex Pharmaceuticals Incorporated: Corporate Venturing by Geography (2020 - YTD*2024)
Figure 8: Vertex Pharmaceuticals Incorporated: Partnership Volume and Value Trend (2020 - YTD*2024)
Figure 9: Vertex Pharmaceuticals Incorporated: Partnership Trend by Deal Type (2020 - YTD*2024)
